Company profile · Zorg & welzijn
DiaphOne Therapeutics
- Biotechnology
- Zorg & welzijn
- Amsterdam
- Biotechnology · Amsterdam
- Employees
- 2–10
- Founded
- 2024
- Province
- Noord-Holland
- Country
- Netherlands
About DiaphOne Therapeutics
DiaphOne Therapeutics (an NLC Health Ventures company) is an early stage biotech company developing small molecules for diabetic complications and other unmet needs. The first-in-class small molecules specifically target the RAGE-DIAPH1 pathway and have shown promising results in treating neurodegeneration and cancer. The company has a solid IP portfolio and is driven by a team of exceptional scientists and entrepreneurs with 30+ years of experience. DiaphOne is currently fundraising a Seed round.
Address
Headquarters
AmsterdamNoord-Holland, Netherlands
Similar companies
Companies with a similar profile, Noord-Holland first.
Kiadis Pharma
Biotechnology · Amsterdam
51–200 employeesView profile
LipidEra Therapeutics
Biotechnology · Amsterdam
2–10 employeesView profile
First Health Pharmaceuticals B.V.
Biotechnology · Amsterdam
11–50 employeesView profile
Neogene Therapeutics
Biotechnology · Amsterdam
51–200 employeesView profile
Nature Innovation Laboratory
Research · Amsterdam
2–10 employeesView profile
Madam Therapeutics
Pharmaceuticals · Amsterdam
2–10 employeesView profile